Pelthos Therapeutics Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Pelthos Therapeutics Inc 's inventory turnover ratio, the ratio that measures Pelthos Therapeutics Inc 's ability to manage its supply chain, sequentially decreased to 0.32 in the first quarter 2026, but it does not raise any concerns as Pelthos Therapeutics Inc continue to execute well, and the inventory turnover ratio remains above the average. Pelthos Therapeutics Inc 's average inventory processing period in the Mar 31 2026 quarter, has increased to 1141 days, from 1106 days, in the Dec 31 2025 quarter.

Within Healthcare sector Pelthos Therapeutics Inc achieved the highest inventory turnover ratio. While inventory turnover ranking remained unchanged in the First Quarter 2026 compared to previous quarter at no. .

PTHS Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Pelthos Therapeutics Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

PTHS Inventory Turnover Ratio	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Inventory Growth	-	-	-	-	-
Y / Y Cost of Sales Growth	-	-	-	-	-
Inventory Turnover Ratio (TTM)	0.32	0.33	0.38	-	-
PTHS's Total Ranking	#	#	#	#	#
Average inventory processing period	1146	1091	949	-	-
Seq. Inventory Growth	-0.66 %	-2.17 %	-	-	-
Seq. Cost of Sales Growth	0.06 %	-27.81 %	-	-	-

Inventory Turnover Ratio Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	#
Healthcare Sector	#
Overall Market	#

Inventory Turnover Ratio Statistics
High	Average	Low
0	0	0

PTHS Company Profile >> Back to PTHS Efficiency Comparisons >> Compare PTHS Inventory Turnover Ratio to its Competitors

Financial Statements
Pelthos Therapeutics Inc 's Inventories	$ 23 Millions	Visit PTHS's Balance sheet
Pelthos Therapeutics Inc 's Cost of Revenues TTM	$ 6 Millions	Visit PTHS's Income Statement
What are PTHS's Sales?		Visit PTHS's Sales by Segment

Other Inventory Turnover Ratios
Pelthos Therapeutics Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Biotechnology & Pharmaceuticals Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
PTHS's Inventory Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for PTHS's Competitors
Inventory Turnover Ratio for PTHS's Suppliers
Inventory Turnover Ratio for PTHS's Customers

You may also want to know
PTHS's Sales Growth Rates	PTHS's Pe Price to earnings ratio	PTHS's Receivables Turnover Ratio	PTHS's Stock Quote
PTHS's Net Income Growth Rates	PTHS's Ps Price to Sales ratio	PTHS's Sales per Employee	PTHS's Asset Turnover Ratio
PTHS's Net Margin	PTHS's Pb Price to Book ratio	PTHS's Financial Strength Ratios	PTHS's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Mar 31 2026	Inventories at quarter ending Mar 31 2026
Xeris Biopharma Holdings Inc	0.64	$ 44.415 Millions	$ 69 Millions
Orchestra Biomed Holdings Inc	0.63	$ 0.178 Millions	$ 0 Millions
Envoy Medical Inc	0.61	$ 0.961 Millions	$ 2 Millions
Organogenesis Holdings Inc	0.60	$ 19.764 Millions	$ 33 Millions
Cvrx inc	0.59	$ 7.000 Millions	$ 12 Millions
Gyre Therapeutics Inc	0.59	$ 5.749 Millions	$ 10 Millions
Biomarin Pharmaceutical Inc	0.57	$ 760.883 Millions	$ 1,324 Millions
Envue Medical Inc	0.57	$ 0.708 Millions	$ 1 Millions
Verastem Inc	0.55	$ 0.977 Millions	$ 2 Millions
Heron Therapeutics Inc	0.52	$ 43.000 Millions	$ 82 Millions
Orthopediatrics Corp	0.49	$ 64.000 Millions	$ 130 Millions
Jaguar Health Inc	0.47	$ 4.417 Millions	$ 9 Millions
X4 Pharmaceuticals Inc	0.40	$ 1.639 Millions	$ 4 Millions
Clene Inc	0.40	$ 0.023 Millions	$ 0 Millions
Outlook Therapeutics Inc	0.40	$ 1.408 Millions	$ 4 Millions
Co diagnostics Inc	0.40	$ 0.399 Millions	$ 1 Millions
Regeneron Pharmaceuticals Inc	0.39	$ 1,248.700 Millions	$ 3,191 Millions
Soleno Therapeutics Inc	0.38	$ 3.898 Millions	$ 10 Millions
Guided Therapeutics Inc	0.37	$ 0.196 Millions	$ 1 Millions
Alpha Cognition Inc.	0.31	$ 1.300 Millions	$ 4 Millions
Aditxt Inc	0.31	$ 0.012 Millions	$ 0 Millions
Nexalin Technology Inc	0.31	$ 0.050 Millions	$ 0 Millions
EBR Systems, Inc.	0.30	$ 3.305 Millions	$ 11 Millions
Vystar Corporation	0.27	$ 0.017 Millions	$ 0 Millions
Immunitybio inc	0.25	$ 0.933 Millions	$ 4 Millions
Adagio Medical Holdings inc	0.23	$ 0.431 Millions	$ 2 Millions
Agios Pharmaceuticals Inc	0.20	$ 6.579 Millions	$ 33 Millions
Biocorrx Inc	0.17	$ 0.025 Millions	$ 0 Millions
Bioadaptives Inc	0.17	$ 0.007 Millions	$ 0 Millions
Femasys Inc	0.16	$ 0.914 Millions	$ 6 Millions

Date modified: 2026-08-30T15:06:15+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.